Your email has been successfully added to our mailing list.

×
0.0456129716623731 0.0456129716623731 0.0456129716623731 0.0456129716623731 0.0456129716623731 0.0456129716623731 0.0456129716623731 0.0385664494620397
Stock impact report

Motif Bio Confirms Meeting Date with U.S. FDA regarding Iclaprim

MOTIF BIO PLC ADRS (MTFB) 
US:NASDAQ Investor Relations: ir.motifbio.com
Company Research Source: GlobeNewswire
NEW YORK, July 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the U.S. Food & Drug Administration (FDA) has granted the Company’s request for a Type B meeting related to a proposed clinical study for the Company’s lead product candidate, iclaprim. The in person meeting has been scheduled for September 19, 2019. As previously announced, Motif Bio submitted a meeting request and clinical study proposal to the FDA based upon the minutes from a May 3, 2019, Type A meeting with the Agency, which indicated that an additional clinical trial will be required prior to granting marketing approval for iclaprim. The Company was encouraged by the FDA to put forth a proposal for such a study, and Motif Bio plans to discuss the proposed patient population and study design with the Agency at the upcoming meeting. Official meeting minutes are received from the FDA typically Show less Read more
Impact Snapshot
Event Time:
MTFB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MTFB alerts
Opt-in for
MTFB alerts

from News Quantified
Opt-in for
MTFB alerts

from News Quantified